Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01129635 · ClinicalTrials.gov registry record · NA
Optimal Coronary Sinus Lead Implantation Using Intracardiac Impedography and Magnetic Resonance Imaging
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT01129635 is a NA study that has completed, run by Emory University. The registered enrollment target is 38 participants.
The verdict
NCT01129635, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Despite the dramatic effect of cardiac resynchronization therapy (CRT) on survival and morbidity in people with congestive heart failure, 50-70% of eligible patients do not respond to this intervention. There is retrospective evidence that placement of the left ventricular (LV) lead at the region of latest mechanical delay markedly improves response to CRT. However, there is no feasible way to gauge dyssynchrony at LV lead sites during CRT implantation. Impedance recordings from pacing lead tips allow for real-time assessment of mechanical motion and may represent a useful intraoperative tool to guide optimum placement of the LV lead during CRT implantation. This pilot trial will assess the use of intraoperative impedograms in humans to measure regional dyssynchrony at potential LV lead locations during CRT implantation.
Interventions
- PROCEDURE Cardiac Resynchronization Therapy (CRT) implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2010-06 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01129635
The ClinicalTrials.gov registry entry for NCT01129635 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Resynchronization Therapy (CRT) implantation is the first listed.
NCT01129635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01129635 about?
NCT01129635 is a clinical study titled "Optimal Coronary Sinus Lead Implantation Using Intracardiac Impedography and Magnetic Resonance Imaging". Despite the dramatic effect of cardiac resynchronization therapy (CRT) on survival and morbidity in people with congestive heart failure, 50-70% of eligible patients do not respond to this intervention. There is retrospective evidence that placement of the left ventricular (LV) lead at the region of...
What is the current status of trial NCT01129635?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2010-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01129635?
The interventions under investigation include: Cardiac Resynchronization Therapy (CRT) implantation (PROCEDURE).
Who is sponsoring clinical trial NCT01129635?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.